Lv61
1770 积分 2023-01-29 加入
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial
7小时前
已完结
Rewiring immunity with in vivo CAR T cell engineering
6天前
已完结
Cellular Immunogenicity Assessments in CAR-T Cell Therapies: Current Insights and Future Directions
11天前
已完结
The Pharmacology of CAR T Cell Therapy for Autoimmune Disease
21天前
已完结
Are the current preclinical models adequate to evaluate CAR-T cell therapy in pediatric high-grade gliomas?
25天前
已完结
The evolution of CAR therapies across oncology and autoimmunity: mechanistic insights and therapeutic innovations
1个月前
已完结
Are the Current Preclinical Models Adequate to Evaluate CAR-T Cell Therapy in Paediatric High-Grade Gliomas?
1个月前
已完结
An immunocompetent bone marrow-on-a-chip model for studying human hematological malignancies and preclinical therapeutic screening
2个月前
已完结
Landmark Long-Term Remission Achieved with ICG318, a BCMA-CD19 Armored Compound CAR T-cell Therapy, in Refractory Systemic Lupus Erythematosus/Lupus Nephritis with Follow-up Approaching 6 Years
2个月前
已完结
Systematic Review of Chimeric Antigen Receptor T-cell Therapy in Autoimmune Diseases
2个月前
已完结
皖公网安备34019202002308
